Arden Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $391K | Sell |
707
-16
| -2% | -$9.17K | 0.05% | 159 |
|
|
2024
Q1 | $420K | Sell |
723
-36
| -5% | -$20.2K | 0.06% | 160 |
|
|
2023
Q4 | $403K | Sell |
759
-87
| -10% | -$42.1K | 0.06% | 161 |
|
|
2023
Q3 | $428K | Sell |
846
-199
| -19% | -$106K | 0.07% | 155 |
|
|
2023
Q2 | $545K | Sell |
1,045
-454
| -30% | -$245K | 0.09% | 139 |
|
|
2023
Q1 | $864K | Sell |
1,499
-443
| -23% | -$250K | 0.16% | 122 |
|
|
2022
Q4 | $1.07M | Sell |
1,942
-189
| -9% | -$100K | 0.22% | 101 |
|
|
2022
Q3 | $1.08M | Sell |
2,131
-29
| -1% | -$16.2K | 0.27% | 88 |
|
|
2022
Q2 | $1.17M | Sell |
2,160
-137
| -6% | -$75.4K | 0.27% | 89 |
|
|
2022
Q1 | $1.36M | Sell |
2,297
-250
| -10% | -$144K | 0.27% | 84 |
|
|
2021
Q4 | $1.7M | Sell |
2,547
-181
| -7% | -$113K | 0.29% | 75 |
|
|
2021
Q3 | $1.56M | Sell |
2,728
-144
| -5% | -$79K | 0.27% | 85 |
|
|
2021
Q2 | $1.45M | Sell |
2,872
-253
| -8% | -$119K | 0.24% | 88 |
|
|
2021
Q1 | $1.43M | Sell |
3,125
-455
| -13% | -$217K | 0.24% | 88 |
|
|
2020
Q4 | $1.67M | Sell |
3,580
-122
| -3% | -$57.2K | 0.28% | 74 |
|
|
2020
Q3 | $1.63M | Buy |
3,702
+220
| +6% | +$90.9K | 0.29% | 70 |
|
|
2020
Q2 | $1.26M | Sell |
3,482
-152
| -4% | -$50.9K | 0.23% | 88 |
|
|
2020
Q1 | $1.03M | Sell |
3,634
-286
| -7% | -$90.2K | 0.21% | 98 |
|
|
2019
Q4 | $1.27M | Sell |
3,920
-166
| -4% | -$50.3K | 0.2% | 105 |
|
|
2019
Q3 | $1.19M | Buy |
4,086
+231
| +6% | +$66.1K | 0.19% | 115 |
|
|
2019
Q2 | $1.13M | Sell |
3,855
-515
| -12% | -$142K | 0.19% | 120 |
|
|
2019
Q1 | $1.2M | Sell |
4,370
-348
| -7% | -$86.6K | 0.19% | 118 |
|
|
2018
Q4 | $1.06M | Sell |
4,718
-518
| -10% | -$122K | 0.19% | 113 |
|
|
2018
Q3 | $1.28M | Sell |
5,236
-825
| -14% | -$190K | 0.2% | 105 |
|
|
2018
Q2 | $1.26M | Sell |
6,061
-294
| -5% | -$62.4K | 0.2% | 111 |
|
|
2018
Q1 | $1.31M | Sell |
6,355
-217
| -3% | -$45.5K | 0.2% | 107 |
|
|
2017
Q4 | $1.25M | Buy |
6,572
+396
| +6% | +$75.9K | 0.19% | 110 |
|
|
2017
Q3 | $1.17M | Sell |
6,176
-93
| -1% | -$16.8K | 0.18% | 120 |
|
|
2017
Q2 | $1.09M | Sell |
6,269
-327
| -5% | -$54.9K | 0.17% | 124 |
|
|
2017
Q1 | $1.01M | Sell |
6,596
-2,237
| -25% | -$342K | 0.16% | 127 |
|
|
2016
Q4 | $1.25M | Sell |
8,833
-200
| -2% | -$29.5K | 0.19% | 108 |
|
|
2016
Q3 | $1.44M | Sell |
9,033
-21,883
| -71% | -$3.37M | 0.22% | 95 |
|
|
2016
Q2 | $4.57K | Buy |
30,916
+258
| +0.8% | +$38.1K | 0.34% | 75 |
|
|
2016
Q1 | $4.34M | Buy |
30,658
+2,375
| +8% | +$318K | 0.35% | 74 |
|
|
2015
Q4 | $4.01M | Sell |
28,283
-181
| -0.6% | -$24.1K | 0.34% | 74 |
|
|
2015
Q3 | $3.48M | Buy |
28,464
+10,274
| +56% | +$1.34M | 0.29% | 89 |
|
|
2015
Q2 | $2.36K | Sell |
18,190
-207
| -1% | -$27K | 0.35% | 72 |
|
|
2015
Q1 | $2.47K | Buy |
18,397
+6,875
| +60% | +$886K | 0.36% | 70 |
|
|
2014
Q4 | $1.44M | Sell |
11,522
-626
| -5% | -$76.1K | 0.2% | 105 |
|
|
2014
Q3 | $1.48M | Sell |
12,148
-548
| -4% | -$66.6K | 0.2% | 100 |
|
|
2014
Q2 | $1.5M | Sell |
12,696
-780
| -6% | -$91.8K | 0.2% | 101 |
|
|
2014
Q1 | $1.62M | Sell |
13,476
-3,098
| -19% | -$368K | 0.2% | 97 |
|
|
2013
Q4 | $1.85M | Sell |
16,574
-1,113
| -6% | -$111K | 0.22% | 88 |
|
|
2013
Q3 | $1.63M | Sell |
17,687
-10,681
| -38% | -$966K | 0.21% | 89 |
|
|
2013
Q2 | $2.4M | Buy |
+28,368
| New | +$2.36M | 0.29% | 67 |
|
Other funds holding TMO
Arden Trust's TMO Position: Q2 2024 in Review
Arden Trust reduced its Thermo Fisher Scientific (TMO) stake by 2.2% in Q2 2024, selling an estimated $9.17K and leaving 707 shares worth $391K. The position accounts for 0.05% of the portfolio, ranked #159.
Arden Trust first reported a position in TMO in Q2 2013 and has held it in 45 quarters since. The position peaked at $4.34M in Q1 2016. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.
- Arden Trust held 707 shares of Thermo Fisher Scientific worth $391K as of Q2 2024.
- Arden Trust sold 16 Thermo Fisher Scientific shares in Q2 2024, an estimated $9.17K.
- Thermo Fisher Scientific made up 0.05% of Arden Trust's portfolio in Q2 2024, its #159 holding.
- Arden Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 45 quarters since.
- Arden Trust's Thermo Fisher Scientific position peaked at $4.34M in Q1 2016.
- 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.
Based on Arden Trust's 13F filing for Q2 2024, filed 9 Jul 2024.